tiprankstipranks
Trending News
More News >
Ping An Healthcare and Technology Company Limited (HK:1833)
:1833

Ping An Healthcare and Technology Company (1833) AI Stock Analysis

Compare
16 Followers

Top Page

HK:1833

Ping An Healthcare and Technology Company

(1833)

Select Model
Select Model
Select Model
Neutral 45 (OpenAI - 4o)
Rating:45Neutral
Price Target:
HK$16.50
▲(13.09% Upside)
The overall stock score is primarily influenced by mixed financial performance and bearish technical indicators. While the company has strong cash reserves and a high dividend yield, the high P/E ratio and negative market momentum present significant risks. The lack of earnings call data and corporate events further limits positive influences on the score.
Positive Factors
Strong Cash Reserves
Strong cash reserves provide financial stability and flexibility, allowing the company to invest in growth opportunities and weather economic downturns.
Revenue Growth
Consistent revenue growth demonstrates the company's ability to expand its market presence and enhance its service offerings, supporting long-term business sustainability.
Improved Cash Flow
Improved cash flow generation enhances the company's ability to fund operations and invest in strategic initiatives, contributing to long-term financial health.
Negative Factors
Inconsistent Profitability
Inconsistent profitability can hinder the company's ability to sustain growth and invest in new opportunities, posing a risk to its long-term financial stability.
Negative Margins
Negative margins indicate operational inefficiencies and can limit the company's ability to generate profits, affecting its competitive position in the long run.
Free Cash Flow Instability
Inconsistent free cash flow can constrain the company's ability to invest in growth initiatives and respond to market changes, impacting long-term strategic goals.

Ping An Healthcare and Technology Company (1833) vs. iShares MSCI Hong Kong ETF (EWH)

Ping An Healthcare and Technology Company Business Overview & Revenue Model

Company DescriptionPing An Healthcare and Technology Company Limited, together with its subsidiaries, operates an online healthcare services platform in the People's Republic of China. It offers online medical services, such as online consultation, hospital referral and appointment, inpatient arrangement, and second opinion services; and consumer healthcare services, including various standardized service packages that integrate services at healthcare institutions. The company also provides healthcare products comprising medicines, health supplements, and medical devices; wellness products comprising fitness equipment and accessories, and personal care products; and other products. In addition, it offers health management and wellness interaction services, such as wellness programs, tools and activities, and personalized content. Further, the company provides medicine marketing services; technology services; application development and operation services; and hospital and clinic services, as well as operates an insurance agency. Ping An Healthcare and Technology Company Limited was incorporated in 2014 and is headquartered in Shanghai, China.
How the Company Makes MoneyPing An Healthcare and Technology generates revenue through multiple streams. Its primary revenue comes from online healthcare services, including telemedicine consultations and health management solutions, which attract a wide user base due to their convenience and accessibility. The company also earns income from partnerships with hospitals and healthcare providers, enabling a comprehensive service network. Additionally, it offers insurance services, which contribute to its financial performance. Strategic collaborations with technology firms enhance its service offerings and expand its market reach, further solidifying its revenue model.

Ping An Healthcare and Technology Company Financial Statement Overview

Summary
Ping An Healthcare and Technology Company displays mixed financial health. While there are positive signs in cash reserves and recent profitability improvements, the company faces challenges with maintaining consistent revenue growth and profitability. The balance sheet remains robust with low leverage, but operational efficiency needs to be enhanced to support sustainable growth.
Income Statement
45
Neutral
The company shows a concerning trend in profitability with negative EBIT and EBITDA margins over the years. However, there is a recent improvement in net income, indicating potential recovery. The gross profit margin remains healthy, but revenue growth has been volatile, signaling uncertainty in financial performance.
Balance Sheet
55
Neutral
The company maintains strong cash reserves as indicated by the substantial cash and short-term investments. The debt-to-equity ratio is low, suggesting conservative use of leverage. However, the return on equity is weak due to inconsistent net income, which could be a potential risk if profitability does not stabilize.
Cash Flow
50
Neutral
There is a positive shift in operating cash flow, moving from negative to positive, suggesting improvement in cash generation. However, free cash flow remains inconsistent, which could impact future investments. The free cash flow to net income ratio shows improvement, but overall cash flow stability needs attention.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue5.22B4.81B4.67B6.21B7.33B6.87B
Gross Profit1.69B1.52B1.51B1.67B1.71B1.86B
EBITDA332.77M193.43M-164.23M-1.05B-1.76B-605.20M
Net Income158.94M81.43M-322.59M-636.06M-1.54B-948.48M
Balance Sheet
Total Assets12.95B16.78B16.52B17.14B17.88B18.56B
Cash, Cash Equivalents and Short-Term Investments7.76B11.52B11.35B10.14B10.14B13.53B
Total Debt45.97M45.00M93.61M176.49M201.29M113.97M
Total Liabilities3.26B13.20B3.25B3.68B3.79B2.71B
Stockholders Equity9.70B3.59B13.28B13.46B14.08B15.83B
Cash Flow
Free Cash Flow270.60M65.08M-325.82M-845.05M-1.49B-1.18B
Operating Cash Flow297.89M99.33M-282.86M-810.62M-1.40B-1.10B
Investing Cash Flow3.49B114.65M-1.49B1.71B-3.10B-2.50B
Financing Cash Flow-3.94B-38.44M-67.36M-317.88M-319.91M6.92B

Ping An Healthcare and Technology Company Technical Analysis

Technical Analysis Sentiment
Positive
Last Price14.59
Price Trends
50DMA
14.93
Negative
100DMA
16.23
Negative
200DMA
12.00
Positive
Market Momentum
MACD
-0.26
Negative
RSI
51.05
Neutral
STOCH
59.57
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1833, the sentiment is Positive. The current price of 14.59 is above the 20-day moving average (MA) of 14.39, below the 50-day MA of 14.93, and above the 200-day MA of 12.00, indicating a neutral trend. The MACD of -0.26 indicates Negative momentum. The RSI at 51.05 is Neutral, neither overbought nor oversold. The STOCH value of 59.57 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:1833.

Ping An Healthcare and Technology Company Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
72
Outperform
HK$24.24B41.9424.57%0.67%13.58%24.59%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
46
Neutral
HK$308.00M-6.91-35.99%-5.38%63.93%
45
Neutral
HK$31.54B151.191.37%14.56%
45
Neutral
HK$16.55B-21.36-15.75%102.73%38.42%
40
Neutral
HK$1.12B-6.06-12.97%-32.17%-1.20%
39
Underperform
HK$4.58B-54.58-2.23%-4.99%47.18%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:1833
Ping An Healthcare and Technology Company
14.59
8.11
125.15%
HK:1952
Everest Medicines Ltd.
46.82
-2.88
-5.79%
HK:2158
Yidu Tech, Inc.
4.95
-0.55
-10.00%
HK:2159
Mediwelcome Healthcare Management & Technology Inc.
1.10
0.58
111.54%
HK:2251
Beijing Airdoc Technology Co. Ltd. Class H
11.37
-0.69
-5.72%
HK:2276
Shanghai Conant Optical Co. Ltd. Class H
50.50
33.35
194.46%

Ping An Healthcare and Technology Company Corporate Events

Ping An Healthcare Establishes Sustainable Development Committee to Enhance ESG Practices
Oct 23, 2025

Ping An Healthcare and Technology Company Limited has established a Sustainable Development Committee under its Board of Directors to enhance corporate governance and address environmental, social, and governance (ESG) responsibilities. This initiative aims to align the company’s operations with sustainable practices, ensuring that its ESG policies remain relevant and effectively implemented, thereby potentially improving its industry positioning and stakeholder relations.

Ping An Healthcare Reports Strong Growth in 2025 with Enhanced AI and Service Expansion
Oct 23, 2025

Ping An Healthcare and Technology Company Limited reported a 13.6% increase in revenue and a 45.7% rise in adjusted net profit for the first nine months of 2025, driven by the expansion of its insurance and healthcare synergies and corporate health management business. The company enhanced its AI capabilities, improving service quality and efficiency, and expanded its user base for family doctor and home-based senior care services, reflecting its strategic focus on integrating online and offline healthcare solutions.

Ping An Healthcare Schedules Board Meeting for Q3 Results
Oct 10, 2025

Ping An Healthcare and Technology Company Limited has announced a board meeting scheduled for October 23, 2025, to review and approve the unaudited third quarterly results for the nine months ending September 30, 2025. This meeting is significant as it will provide insights into the company’s financial performance and could impact its market positioning and stakeholder confidence.

Ping An Healthcare Announces Leadership Changes
Oct 7, 2025

Ping An Healthcare and Technology Company Limited has announced a significant leadership change with the resignation of Mr. Dou Li as Chairman, Executive Director, and CEO, effective October 7, 2025, due to personal work arrangements. Mr. Michael Guo, a non-executive director with extensive experience in the Ping An Group, has been appointed as the new Chairman, while Mr. Mingke He, who brings a wealth of experience from various industries, has been appointed as the new CEO and Executive Director. These changes are expected to maintain the company’s operational stability and continue its efficient corporate governance.

Ping An Healthcare Announces Board Composition and Roles
Oct 7, 2025

Ping An Healthcare and Technology Company Limited has announced the composition of its board of directors, highlighting the roles and functions of each member. This announcement may impact the company’s governance and strategic direction, potentially influencing its market positioning and stakeholder relations.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 29, 2025